October 4, 2011 – The International Contrast Ultrasound Society (ICUS) submitted a petition this week to the U.S. Food ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
Several positron emission tomography (PET) imaging agents are being developed to visualize Alzheimer’s disease in the ...
August 23, 2011 — PLC Systems Inc. said the final results from the REMEDIAL II investigator-sponsored clinical trial ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
August 9, 2011 — Acist Medical Systems Inc., a Bracco Group company and provider of advanced contrast injection system ...
July 29, 2011 — Oxygen Biotherapeutics Inc. and privately held Aurum Biosciences Ltd. of Glasgow, Scotland, have signed ...
June 14, 2011 – GE Healthcare Medical Diagnostics announced results of a study evaluating the cardiopulmonary safety of ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
May 20, 2011 – Medrad Inc., a business of Bayer HealthCare, has announced the launch of the next generation Intego PET ...
May 10, 2011 – A simple blood test may help prevent a serious complication associated with a contrast agent commonly ...
Over the past few years, the trends in automated imaging contrast media injection systems have included the conversion ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
March 25, 2011 – The diagnostic imaging business unit of Bayer Vital GmbH and Vital Images, have signed a cooperation ...
March 15, 2011 – The U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection, a macrocyclic ...
February 14, 2011 – A new bedside insertion kit and power-injectable catheter has been launched. The Morpheus Smart PICC ...
With the use of contrast agents and radiotracers on the rise, GE Healthcare has seen increases in demand across their ...
February 10, 2011 – Pre-clinical studies have demonstrated that improved drug uptake in tumors can be visualized and ...
January 24, 2011 – Lantheus Medical Imaging has entered into a contract with Novation for Ablavar (gadofosveset ...
Contrast-enhanced ultrasound (CEUS) can "dramatically improve" physicians' ability to detect heart disease and stratify ...
January 24, 2011 – A U.S. Food and Drug Administration’s (FDA) panel voted unanimously last week to recommend the ...
December 17, 2010 – An ultrasound contrast agent is under review by the U.S. Food and Drug Administration (FDA) for use ...
December 16, 2010 – Bracco Imaging demonstrated how its customized evidence-based diagnostic imaging solutions are ...
November 12, 2010 – A noninvasive imaging technique may help effectively diagnose prostate cancer at an early stage ...
November 10, 2010 — Results from the first head-to-head taste test of oral contrast agents indicate a significantly ...